Your browser doesn't support javascript.
loading
A prospective randomised phase II trial of thalidomide with carboplatin compared with carboplatin alone as a first-line therapy in women with ovarian cancer, with evaluation of potential surrogate markers of angiogenesis.
Muthuramalingam, S R; Braybrooke, J P; Blann, A D; Madhusudan, S; Wilner, S; Jenkins, A; Han, C; Kaur, K; Perren, T; Ganesan, T S.
Afiliación
  • Muthuramalingam SR; Cancer Research UK Medical Oncology Unit, University of Oxford, Churchill Hospital, Oxford.
Eur J Gynaecol Oncol ; 32(3): 253-8, 2011.
Article en En | MEDLINE | ID: mdl-21797111
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Talidomida / Carcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Carboplatino Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Eur J Gynaecol Oncol Año: 2011 Tipo del documento: Article
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Talidomida / Carcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Carboplatino Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Eur J Gynaecol Oncol Año: 2011 Tipo del documento: Article
...